TRAIL, a member of TNF superfamily, is a potent inducer of neuronal death. Neurotoxic effects of TRAIL appear mediated by its death receptor TRAIL-R2/DR5. To assess the role of TRAIL/TRAIL-R2 pathway in AD-related neurodegeneration, we studied the impact of the treatment with amyloid-beta (A beta) upon cell viability and inflammation in TRAIL-R-deficient mice (TRAIL-R-/-). Here, we demonstrate that the lack of TRAIL-R2 protects from death cultured TRAIL-R-/- mouse embryonic hippocampal cells after treatment with either A beta 1-42 or TRAIL. Consistently, stereotaxic injection of A beta 1-42 resulted in blunted caspase activation, as well as in reduction of JNK phosphorylation and increased AKT phosphorylation in TRAIL-R-/- mice. Moreover, the lack of TRAIL-R2 was associated with blunted constitutive p53 expression in mice that have undergone A beta 1-42 treatment, as well as in decrease of phosphorylated forms of tau and GSK3 beta proteins. Likewise, TRAIL-R2 appears essential to both TRAIL and A beta-mediated neurotoxicity and inflammation. Indeed, hippocampi of TRAIL-R-/- mice challenged with A beta 1-42, showed a slight expression of microglial (Iba-1) and astrocytic (GFAP) markers along with attenuated levels of IL-1 beta, TNF-alpha, NOS2 and COX2. In conclusion, the bulk of these results demonstrate that the constitutive lack of TRAIL-R2 is associated with a substantial reduction of noxious effects of A beta 1-42, providing further evidence on the prominent role played by TRAIL in course of A beta-related neurodegeneration and confirming that the TRAIL system represents a potential target for innovative AD therapy.

TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β

Di Benedetto, Giulia;Burgaletto, Chiara;Serapide, Maria Francesca;Caltabiano, Rosario;Bellanca, Carlo Maria;Di Mauro, Rosaria;Bernardini, Renato
;
Cantarella, Giuseppina
2022

Abstract

TRAIL, a member of TNF superfamily, is a potent inducer of neuronal death. Neurotoxic effects of TRAIL appear mediated by its death receptor TRAIL-R2/DR5. To assess the role of TRAIL/TRAIL-R2 pathway in AD-related neurodegeneration, we studied the impact of the treatment with amyloid-beta (A beta) upon cell viability and inflammation in TRAIL-R-deficient mice (TRAIL-R-/-). Here, we demonstrate that the lack of TRAIL-R2 protects from death cultured TRAIL-R-/- mouse embryonic hippocampal cells after treatment with either A beta 1-42 or TRAIL. Consistently, stereotaxic injection of A beta 1-42 resulted in blunted caspase activation, as well as in reduction of JNK phosphorylation and increased AKT phosphorylation in TRAIL-R-/- mice. Moreover, the lack of TRAIL-R2 was associated with blunted constitutive p53 expression in mice that have undergone A beta 1-42 treatment, as well as in decrease of phosphorylated forms of tau and GSK3 beta proteins. Likewise, TRAIL-R2 appears essential to both TRAIL and A beta-mediated neurotoxicity and inflammation. Indeed, hippocampi of TRAIL-R-/- mice challenged with A beta 1-42, showed a slight expression of microglial (Iba-1) and astrocytic (GFAP) markers along with attenuated levels of IL-1 beta, TNF-alpha, NOS2 and COX2. In conclusion, the bulk of these results demonstrate that the constitutive lack of TRAIL-R2 is associated with a substantial reduction of noxious effects of A beta 1-42, providing further evidence on the prominent role played by TRAIL in course of A beta-related neurodegeneration and confirming that the TRAIL system represents a potential target for innovative AD therapy.
Alzheimer’s disease
TRAIL-R2
neuroinflammation
Amyloid beta-Peptides
Inflammation
Mice, Knockout
Tumor Suppressor Protein p53
Receptors, TNF-Related Apoptosis-Inducing Ligand
Tumor Necrosis Factor-alpha
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/541660
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact